Jing Jin, MD, PhD was originally trained as a clinical doctor and then set out on a career path to pursue basic research that explores the molecular mechanisms of human physiology and disease. In recent years, his work has become more focused on “technology-driven fields,” involving cutting-edge proteomics tools to study basic intracellular signaling processes.
His new appointment as a Principal Investigator in the Department of Medicine–Nephrology and the Feinberg Cardiovascular Research Institute at Northwestern University Feinberg School of Medicine provides the perfect opportunity to apply his knowledge and expertise to address fundamental questions in kidney and vascular diseases. Throughout his training, he has been fortunate to be associated with top institutions, allowing him to develop his skills across broad areas of research.
Dr. Jin first studied medicine at the Peking University Medical School in Beijing, China and graduated with a medical degree. He completed his residency training in cardiology at the Cardiovascular Institute and Fuwai Hospital of the Chinese Academy of Medical Sciences.
He then immigrated to Canada to study with the renowned molecular biologist Jim Woodgett and received his PhD from the University of Toronto. His doctoral thesis focused on the developmental and oncogenic aspects of PI3’K and Akt/PKB signaling pathways. Dr. Jin continued to study cell signaling during his postdoctoral training with Tony Pawson, an internationally recognized expert in proteomics and cell signaling, at Mount Sinai Hospital in Toronto. There, he worked on a variety of projects and developed several novel proteomics and mass spectrometry platforms.
In his new position at Northwestern University, Dr. Jin applies his proteomics and cell signaling expertise to study renal and vascular functions.